Inaugural R&D Day

Monday, September 26, 2022 10:00 am to 12:30 pm EDT
Midtown, New York City

Anebulo Pharmaceuticals Inaugural R&D Day Live Webcast

REGISTER

PRESENTATION

Latest Financial Results

Latest Annual Filing

For Fiscal Year Ending Jun 30, 2022

Cannabis associated ED visits are frequent and rapidly growing

Number of annual cannabis associated emergency department visits in the United States, 2006-2018

Note: Between 21% and 23% of all emergency department visits were captured by the National Emergency Department Sample (NEDS) in the years 2006-2014. The number of visits outside of the NEDS sample was extrapolated. Source for 2006-2014: Shen, J. J., Shan, G., Kim, P. C., Yoo, J. W., Dodge-Francis, C., & Lee, Y.-J. (2018). Trends and Related Factors of Cannabis-Associated Emergency Department Visits in the United States. Journal of Addiction Medicine, 1. doi:10.1097/adm.0000000000000479, Source for 2015-2018: Company analysis of NEDS database

Marijuana legalization is increasing

IR Contacts

Company

Anebulo Pharmaceuticals, Inc.
1415 Ranch Road 620 South
Austin, TX 78734
T: 512-598-0931
ir@anebulo.com

Investor Relations

Scott L. Anderson
T: (858) 229-7063
scott@anebulo.com

Madison Damour
madison@anebulo.com

Transfer Agent

Continental Stock Transfer & Trust Company
17 Battery Place
8th Floor
New York, NY 10004

Market Data copyright © 2022 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.